Bowman–Birk Inhibitor Mutants of Soybean Generated by CRISPR-Cas9 Reveal Drastic Reductions in Trypsin and Chymotrypsin Inhibitor Activities
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25115578 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Won-Seok Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plant Science and Technology, University of Missouri, Columbia, MO 65211, USA. Hauptthemen laut MEDLINE: Gene Editing, Glycine max, Trypsin Inhibitor, Bowman-Birk Soybean. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United Soybean Board and Agricultural Research Service, USDA, Minnesota Soybean Research and Promotion Council project, United Soybean Board.
Abstract (Originalsprache)
Despite the high quality of soybean protein, raw soybeans and soybean meal cannot be directly included in animal feed mixtures due to the presence of Kunitz (KTi) and Bowman–Birk protease inhibitors (BBis), which reduces animal productivity. Heat treatment can substantially inactivate trypsin and chymotrypsin inhibitors (BBis), but such treatment is energy-intensive, adds expense, and negatively impacts the quality of seed proteins. As an alternative approach, we have employed CRISPR/Cas9 gene editing to create mutations in BBi genes to drastically lower the protease inhibitor content in soybean seed. Agrobacterium-mediated transformation was used to generate several stable transgenic soybean events. These independent CRISPR/Cas9 events were examined in comparison to wild-type plants using Sanger sequencing, proteomic analysis, trypsin/chymotrypsin inhibitor activity assays, and qRT-PCR. Collectively, our results demonstrate the creation of an allelic series of loss-of-function mutations affecting the major BBi gene in soybean. Mutations in two of the highly expressed seed-specific BBi genes lead to substantial reductions in both trypsin and chymotrypsin inhibitor activities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Plant Science and Technology, University of Missouri, Columbia, MO 65211, USA.
- Plant Genetics Research Unit, US Department of Agriculture-Agricultural Research Service, Columbia, MO 65211, USA.
- Department of Agronomy and Plant Genetics, University of Minnesota, St. Paul, MN 55108, USA.
- Institute of Genomics for Crop Abiotic Stress Tolerance, Texas Tech University, Lubbock, TX 79409, USA.
ORCID-Profile: Jason D Gillman, Madhusudhana R Janga, Robert M Stupar
Förderung
- United Soybean Board and Agricultural Research Service, USDA
- Minnesota Soybean Research and Promotion Council project
- United Soybean Board
- Agricultural Research Service, USDA
- Minnesota Soybean Research and Promotion Council
Zitieren
APA
Kim, W. S., Gillman, J. D., Kim, S., Liu, J., Janga, M. R., Stupar, R. M., & Krishnan, H. B. (2024). Bowman–Birk Inhibitor Mutants of Soybean Generated by CRISPR-Cas9 Reveal Drastic Reductions in Trypsin and Chymotrypsin Inhibitor Activities. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25115578
Vancouver
Kim WS, Gillman JD, Kim S, Liu J, Janga MR, Stupar RM, et al. Bowman–Birk Inhibitor Mutants of Soybean Generated by CRISPR-Cas9 Reveal Drastic Reductions in Trypsin and Chymotrypsin Inhibitor Activities. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25115578
BibTeX
@article{Kim2024,
author = {Kim, Won-Seok and Gillman, Jason D and Kim, Sunhyung and Liu, Junqi and Janga, Madhusudhana R and Stupar, Robert M and Krishnan, Hari B},
title = {Bowman–Birk Inhibitor Mutants of Soybean Generated by CRISPR-Cas9 Reveal Drastic Reductions in Trypsin and Chymotrypsin Inhibitor Activities},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25115578}
}
EUVIMED